Loading stock data…
ABVC Biopharma, Inc. (ABVC)
$1.57+0.04 (+2.61%)
Market OpenUpdated 1:57 PM EDT
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
ABVC BioPharma, Inc. in the Healthcare sector is trading at $1.57 with a market capitalization of $33M. The stock is currently near its 52-week low of $0.88, remaining 19.5% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0↑ | -$795,950 | $0 | $0 | $0 |
| Gross Profit | $0↑ | -$795,950 | $0 | $0 | $0 |
| Operating Income | -$1.57M↑ | -$2.99M↓ | -$1.96M↑ | -$2.29M↓ | -$693,005 |
| Net Income | -$1.56M↑ | -$3.56M↓ | -$2.04M↑ | -$2.26M↓ | -$842,075 |
Peer Comparison
JNJUNHPFE
Fundamentals
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therap...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$33.28M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.42
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-87.47%
Volume
Today's trading volume
137,003
Recent News
ABVC BioPharma, Inc. (ABVC) Reports 103% Asset Surge, Eyeing Phase III Trials for Depression Therapies
In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. ABVC BioPharma, Inc. is one of them. ABVC BioPharma, Inc. (NASDAQ:ABVC) tops our list for being one of the best penny stocks. It is a clinical-stage biopharmaceutical company developing botanically derived therapeutics for oncology, neurology, […]
ABVC BioPharma First Half 2025 Earnings: US$0.19 loss per share (vs US$0.36 loss in 1H 2024)
NasdaqCM:ABVC 1 Year Share Price vs Fair Value Explore ABVC BioPharma's Fair Values from the Community and select yours...